Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Aussie opioid manufacturer cashed up following $33m sale of facility
    • News

    Aussie opioid manufacturer cashed up following $33m sale of facility

    While prescription opioids have been getting a pretty bad rap over the past few years amid revelations in the US about a certain Sackler family, they still have a vital role to play in healthcare where good guys like Palla Pharma (ASX: PAL) have strengthened their balance sheet with the sale of their manufacturing facility

    Read More
    Public
  • Australia to close borders to Omicron Persei 8
    • Satire

    Australia to close borders to Omicron Persei 8

    Taking no chances with the latest strain of COVID-19, Australia is set to be the first country in the world to raise its border to travelers arriving from Omicron Persei 8.  Confirming the decision, Health Department representative Richard Handler empathised with Omicronians but stressed that the decision was made in the interest of all Australians. 

    Read More
    Public
  • National expansion continues as Apiam acquire 4 new vet clinics amid revenue surge
    • News

    National expansion continues as Apiam acquire 4 new vet clinics amid revenue surge

    With business booming in response to a 20% increase in pet ownership amongst Australians during the pandemic, veterinary operator Apiam Animal Health (ASX: AHX) has continued its acquisition spree by adding 4 new clinics to their national network. The clinics include 3 in Queensland located within the Fraser Coast region and one located in Armidale,

    Read More
    Public
  • Laying down new roots: Roots ag-tech expands into Africa
    • News

    Laying down new roots: Roots ag-tech expands into Africa

    Anyone who has tried to grow coriander on their apartment balcony (like me) will understand that food production, even that of a measly herb, is somewhat of an art form. The climate, topography and differences in soil all affect the type and quality of foods that can be grown in certain regions.  Adding to an

    Read More
    Public
  • This small biotech is the definition of a quiet achiever, here’s why it might be time to tune in
    • News

    This small biotech is the definition of a quiet achiever, here’s why it might be time to tune in

    Clinical stage pharmaceutical company Pharmaxis (ASX: PXS) is in a transformation phase as their clinical pipeline progresses towards multiple value inflection points.  With two products already on market, the Company has a great base from which to fund their ongoing clinical product development. Adding to that, the company has just completed a capital raise viaRead More
    Public
  • Openn confirms US expansion via Pilot Program for transparent online auctions
    • News

    Openn confirms US expansion via Pilot Program for transparent online auctions

    Property tech company Openn Negotiation (ASX: OPN) is set to enter one of the world’s most lucrative real estate markets with confirmation they will commence a 6-month Pilot Program in the United States for their online auctions platform that offers transparency to buyers – the biggest complaint from buyers dealing with the traditional seller-friendly model. 

    Read More
    Public
  • «
  • ‹
  • 434
  • 435
  • 436
  • 437
  • 438
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.